Genflow Biosciences: AGM and partnership strategy - ICYMI

Genflow Biosciences: AGM and partnership strategy - ICYMI Proactive uses images sourced from Shutterstock Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regarding its upcoming AGM and the strategic rationale behind authorising the potential issuance of shares ahead of clinical partnership discussions. Leire addressed potential shareholder concerns, acknowledging that announcements involving share issuance can sometimes be int ...